Study: NCT00907985

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose of placebo will be provided.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose of placebo will be provided.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose of placebo will be provided.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose of placebo will be provided.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose of placebo will be provided.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose of placebo will be provided.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose of placebo will be provided.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose of placebo will be provided.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose of placebo will be provided.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vofopitant
Description: Vofopitant (GR205171) will be provided as 5 milligram single dose capsule administered orally. It will be available as swedish orange, size 0 capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vofopitant
Description: Vofopitant (GR205171) will be provided as 5 milligram single dose capsule administered orally. It will be available as swedish orange, size 0 capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vofopitant
Description: Vofopitant (GR205171) will be provided as 5 milligram single dose capsule administered orally. It will be available as swedish orange, size 0 capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vofopitant
Description: Vofopitant (GR205171) will be provided as 5 milligram single dose capsule administered orally. It will be available as swedish orange, size 0 capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vofopitant
Description: Vofopitant (GR205171) will be provided as 5 milligram single dose capsule administered orally. It will be available as swedish orange, size 0 capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vofopitant
Description: Vofopitant (GR205171) will be provided as 5 milligram single dose capsule administered orally. It will be available as swedish orange, size 0 capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vofopitant
Description: Vofopitant (GR205171) will be provided as 5 milligram single dose capsule administered orally. It will be available as swedish orange, size 0 capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vofopitant
Description: Vofopitant (GR205171) will be provided as 5 milligram single dose capsule administered orally. It will be available as swedish orange, size 0 capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vofopitant
Description: Vofopitant (GR205171) will be provided as 5 milligram single dose capsule administered orally. It will be available as swedish orange, size 0 capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vofopitant
Description: Vofopitant (GR205171) will be provided as 5 milligram single dose capsule administered orally. It will be available as swedish orange, size 0 capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vofopitant
Description: Vofopitant (GR205171) will be provided as 5 milligram single dose capsule administered orally. It will be available as swedish orange, size 0 capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vofopitant
Description: Vofopitant (GR205171) will be provided as 5 milligram single dose capsule administered orally. It will be available as swedish orange, size 0 capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vofopitant
Description: Vofopitant (GR205171) will be provided as 5 milligram single dose capsule administered orally. It will be available as swedish orange, size 0 capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vofopitant
Description: Vofopitant (GR205171) will be provided as 5 milligram single dose capsule administered orally. It will be available as swedish orange, size 0 capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vofopitant
Description: Vofopitant (GR205171) will be provided as 5 milligram single dose capsule administered orally. It will be available as swedish orange, size 0 capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vofopitant
Description: Vofopitant (GR205171) will be provided as 5 milligram single dose capsule administered orally. It will be available as swedish orange, size 0 capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vofopitant
Description: Vofopitant (GR205171) will be provided as 5 milligram single dose capsule administered orally. It will be available as swedish orange, size 0 capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vofopitant
Description: Vofopitant (GR205171) will be provided as 5 milligram single dose capsule administered orally. It will be available as swedish orange, size 0 capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vofopitant
Description: Vofopitant (GR205171) will be provided as 5 milligram single dose capsule administered orally. It will be available as swedish orange, size 0 capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vofopitant
Description: Vofopitant (GR205171) will be provided as 5 milligram single dose capsule administered orally. It will be available as swedish orange, size 0 capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Description: Lamotrigine will be provided as 25 milligrams or 100 milligrams single dose dispersible tablet administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Description: Lamotrigine will be provided as 25 milligrams or 100 milligrams single dose dispersible tablet administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Description: Lamotrigine will be provided as 25 milligrams or 100 milligrams single dose dispersible tablet administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Description: Lamotrigine will be provided as 25 milligrams or 100 milligrams single dose dispersible tablet administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Description: Lamotrigine will be provided as 25 milligrams or 100 milligrams single dose dispersible tablet administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Description: Lamotrigine will be provided as 25 milligrams or 100 milligrams single dose dispersible tablet administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Description: Lamotrigine will be provided as 25 milligrams or 100 milligrams single dose dispersible tablet administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Description: Lamotrigine will be provided as 25 milligrams or 100 milligrams single dose dispersible tablet administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Description: Lamotrigine will be provided as 25 milligrams or 100 milligrams single dose dispersible tablet administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Description: Lamotrigine will be provided as 25 milligrams or 100 milligrams single dose dispersible tablet administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Description: Lamotrigine will be provided as 25 milligrams or 100 milligrams single dose dispersible tablet administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Description: Lamotrigine will be provided as 25 milligrams or 100 milligrams single dose dispersible tablet administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Description: Lamotrigine will be provided as 25 milligrams or 100 milligrams single dose dispersible tablet administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Description: Lamotrigine will be provided as 25 milligrams or 100 milligrams single dose dispersible tablet administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Description: Lamotrigine will be provided as 25 milligrams or 100 milligrams single dose dispersible tablet administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Description: Lamotrigine will be provided as 25 milligrams or 100 milligrams single dose dispersible tablet administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Description: Lamotrigine will be provided as 25 milligrams or 100 milligrams single dose dispersible tablet administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Description: Lamotrigine will be provided as 25 milligrams or 100 milligrams single dose dispersible tablet administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Description: Lamotrigine will be provided as 25 milligrams or 100 milligrams single dose dispersible tablet administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Description: Lamotrigine will be provided as 25 milligrams or 100 milligrams single dose dispersible tablet administered orally.